In the well-defined Gram-negative bacterium Escherichia coli K-12, LPS/LOS biosynthesis initiates with formation of Kdo 2 -lipid A (Kdo stands for 3-deoxy-D-manno-octulosonic acid) or endotoxin. Nine conserved enzymes, termed the Raetz pathway (1), coordinately synthesize hexa-acylated lipid A. While the first seven enzymes assemble the precursor Kdo 2 -lipid IV A , the last two biosynthetic steps are completed by LpxL and LpxM. LpxL first catalyzes transfer of laurate (C 12:0 ) followed by LpxM-dependent myristate (C 14:0 ) addition in a stepwise manner to complete synthesis of the hexa-acylated and bis-phosphorylated Kdo 2 -lipid A molecule ( Fig. 1) (5-7) .
Despite E. coli K-12 providing a basic model to understand lipid A biosynthesis in Gram-negative bacteria, many pathogens remodel the hexa-acylated molecule into diverse lipid A-based structures. Lipid A modifications directly affect the ability of a pathogen to survive in its host by altering outer membrane permeability, by camouflaging the pathogen from host immune detection, and by promoting resistance to antimicrobial peptides (1, 8) . While pathogens exploit diverse strategies to survive in a host, a detailed understanding of the molecular mechanisms that mediate bacterial survival is key for the development of new and more-effective antimicrobial treatments.
Gram-negative bacteria can alter their lipid A structure by incorporating additional chemical moieties or by altering the lipid A phosphate or acyl chain groups (8, 9) . Well-defined transcriptional and posttranscriptional regulatory systems tightly control the lipid A enzymatic modification machinery, illustrating the importance of lipid A on bacterial survival (8, 10, 11) . One wellcharacterized lipid A modification involves palmitate addition to form hepta-acylated lipid A, which promotes bacterial resistance to cationic antimicrobial peptides (CAMPs), fortifies the outer membrane, and reduces host immune recognition (). In a number of pathogens, hepta-acylation is a protective response to a specific environmental stressor. In the presence of the signal, the bacterium initiates a regulatory phosphorylation cascade that culminates in increased expression of the outer membrane protein PagP (12) . In the outer membrane, PagP transfers a palmitoyl (C 16:0 ) group to lipid A with phosphatidylethanolamine serving as the acyl donor (13) .
Unlike most Gram-negative pathogens, which synthesize hexa-acylated lipid A under standard growth conditions, the nosocomial pathogen Acinetobacter baumannii produces a predominant hepta-acylated lipid A molecule in a PagP-independent fashion (15, 16) . In this study, we investigate the biosynthetic mechanism utilized for production of hepta-acylated lipid A in A. baumannii and characterize how it impacts bacterial fitness.
A. baumannii is a resilient Gram-negative pathogen that is well adapted to survive in hospital or intensive care unit environments. Over the past decade, the rate of A. baumannii transmission and infection in health care communities has significantly increased patient morbidity and mortality (17) . A. baumannii infections are diverse, and treatment options have become extremely limited due to a propensity for A. baumannii to develop resistance to conventional antibiotics. The bacterium develops antibiotic resistance through acquisition of resistance genes, upregulation of efflux pumps, and through modification of outer membrane structures (18) . Oftentimes acquisition of resistance mechanisms results in reduced bacterial fitness (19) (20) (21) . Emergence of multidrug-resistant (MDR) and extensively drug-resistant strains has required increased prescription of last-resort antibiotics (17, (22) (23) (24) (25) . Currently, last-line treatments include a CAMP called colistin which targets lipid A to perturb the membrane and lyse the bacterium (26) . Despite success of last-resort CAMPs like colistin, recent studies have shown that A. baumannii can develop resistance under selective pressure (25) . Therefore, a detailed understanding of the bacterial factors essential for CAMP resistance in A. baumannii is necessary to direct innovative chemotherapeutic strategies.
Another important factor contributing to the spread of A. baumannii is its propensity to withstand desiccation. Uniquely, A. baumannii survives on inanimate objects without nutrients or water for extended periods, which promotes transmission throughout health care environments (27) . The molecular factors that mediate desiccation survival are not well understood, but identification of desiccation fitness determinants could result in more effective eradication strategies.
In this study, we characterized two genes designated lpxL Ab (A. baumannii lpxL) and lpxM Ab (A. baumannii lpxM) that are required for biosynthesis of hepta-acylated lipid A in A. baumannii. Unlike lipid A biosynthesis in most other Gram-negative pathogens, A. baumannii encodes a dual acyltransferase designated LpxM Ab (A. baumannii LpxM), which transfers two lauroyl groups onto lipid A to synthesize hepta-acylated lipid A via a PagP-independent mechanism. Our analysis demonstrated that hepta-acylated lipid A is the dominant glycolipid on the surface of A. baumannii and activates human Toll-like receptor 4 (TLR-4). In contrast, LOS isolated from lpxL Ab and lpxM Ab mutants failed to stimulate the human TLR-4 innate immune pathway. Similar to studies performed in Salmonella, hepta-acylated lipid A promoted bacterial resistance to vertebrate CAMPs (10); however, hepta-acylated lipid A in A. baumannii also conferred resistance to polymyxin CAMPs such as the last-resort antimicrobial agent colistin. In addition, we determined that hepta-acylated lipid A is important for bacterial desiccation survival, indicating that loss of outer membrane fatty acids is detrimental to A. baumannii persistence on inanimate objects in the hospital.
RESULTS

A. baumannii encodes LpxL and LpxM lipid A acyltransferase homologs.
Previous studies to characterize the biosynthesis of lipid A, the bioactive moiety that anchors LPS/LOS to the outer membranes of Gram-negative bacteria, established that two secondary acyltransferases catalyze the final two enzymatic steps. In E. coli, LpxL functions first by transferring a laurate group onto Kdo 2 -lipid IV A followed by myristate addition via LpxM to complete biosynthesis of hexa-acylated Kdo 2 -lipid A ( Fig. 1) (5-7) . The two secondary acylation steps in lipid A biosynthesis are generally conserved among Gram-negative bacteria. However, lipid A secondary acyltransferases that recognize noncanonical substrates in an epsilonproteobacterium have been reported (28) .
Instead of synthesizing hexa-acylated lipid A, like many Gramnegative bacterial pathogens, A. baumannii synthesizes a predominant hepta-acylated lipid A species under normal growth conditions (15, 16) . While the mechanism that leads to A. baumannii lipid A hepta-acylation has not been characterized, analysis of E. coli and Salmonella determined that lipid A hepta-acylation is dependent on the outer membrane protein PagP (Fig. 1) (10, 13, 29) . PagP expression increases in response to specific stimuli that perturb the outer membrane, leading to migration of phospholipids in the outer leaflet (30) . Mechanistically, PagP transfers a palmitate acyl chain (C 16:0 ) from phosphatidylethanolamine to the lipid A R-2-hydroxymyristate to generate hepta-acylated lipid A ( Fig. 1) (13) . In E. coli and Salmonella, palmitate addition protects the cell from vertebrate CAMPs by reducing the permeability of the outer membrane barrier (10) . However, the biological role of hepta-acylated lipid A in A. baumannii has not been examined. Intriguingly, A. baumannii does not carry a gene that encodes a PagP homolog, suggesting that it has evolved a PagP-independent acylation mechanism.
In order to identify putative lipid A acyltransferases in A. (33) . For complementation of each acyltransferase, each respective coding sequence was expressed from an isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible promoter on a replicon in the mutant strain (see Table S1 in the supplemental material). Growth curve analysis of the mutants and complemented strains did not reveal any major growth defect compared with the wild-type strain (see Fig. S1 in the supplemental material).
To analyze the effect on lipid A produced by each A. baumannii strain, 32 P-radiolabeled lipid A was isolated and chromatographically separated based on hydrophobicity. Quantitative thin-layer chromatography (TLC) showed that wild-type A. baumannii produced a predominant hepta-acylated lipid A species with relatively minor amounts of a hexa-acylated species ( Fig Fig. 2C ) and the ⌬lpxM Ab strain revealed one major ion species at m/z 1,546.0 (Fig. 2D ). On the basis of our observed m/z ratios, we proposed chemical structures to fit the exact theoretical mass where wildtype A. baumannii synthesizes two lipid A species, including a minor hexa-acylated lipid A and a predominant hepta-acylated lipid A (Fig. 2B ). Based on our chemical structures in the mutant strains, the ⌬lpxL Ab strain lacked a hydroxylauric acid, while the ⌬lpxM Ab strain resulted in production of penta-acylated lipid A lacking two lauroyl groups ( Fig. 2C and D) .
To verify the A. baumannii lipid A secondary acyl groups, higher-energy collisional dissociation (HCD) and UV photodissociation (UVPD) fragmentation spectra were collected for the previously indicated molecular ions. HCD and UVPD are highenergy ion activation methods that produce rich fragmentation patterns and thus enable a detailed structural analysis (34, 35) . Unique fragments in the HCD and UVPD spectra at m/z 1,911.2, corresponding to wild-type hepta-acylated lipid A, confirmed the presence and length of all seven acyl chains (see Fig. S3 in the supplemental material). Specifically, our analysis revealed four acyl chains attached to the distal side and three on the proximal side of the lipid A molecule as shown in Fig. 3C .
Heterologous expression of LpxM Ab in E. coli revealed dual transferase activity. Previously characterized LpxL and LpxM acyltransferases exclusively add one fatty acid to lipid A (5). However, our data indicated that A. baumannii ⌬lpxM Ab strains lacked two lauroyl groups. To determine whether LpxM Ab is sufficient to catalyze transfer of two laurate groups onto A. baumannii lipid A, we expressed the lpxL Ab and lpxM Ab genetic coding sequences in BN2, an E. coli strain with deletions in both lpxM and pagP. E. coli strain BN2 synthesizes penta-acyl lipid A with one laurate group attached at position 2= (Fig. 3A , leftmost lane) (9) . Expression of LpxL Ab in strain BN2 did not alter the lipid A structure, suggesting that it is not active in E. coli or that it functions like E. coli LpxL and only adds a secondary acyl chain at position 2= (Fig. 3A , middle lane, and Fig. 1 ) (36) . Importantly, expression of LpxM Ab in strain BN2 resulted in formation of both hexa-and hepta-acylated lipid species (Fig. 3A , rightmost lane). Thus, LpxM Ab is sufficient to attach lauroyl groups at two distinct locations of the lipid A molecule, a characteristic unique to LpxM Ab . We confirmed attachment of the acyl chains by mass spectrometry where spectra showed two major species at m/z 1,768.2 and 1,951.2, which indicate two separate acylation sites ( Fig. 3B and C) .
Determining LpxM Ab acyl chain placement and hydroxylation. Importantly, the palmitate acyl chain added by PagP at the R-2-hydroxymyristate position of lipid A in E. coli and Salmonella was shown to be important for resistance against host CAMPs ( Fig. 1) (10) . Therefore, we sought to determine whether placement of the secondary acyl chain in A. baumannii lipid A occurs at an equivalent position.
Formation of hepta-acylated lipid A through addition of an acyl chain onto A. baumannii lipid A at the same site that PagP functions in E. coli and Salmonella could be important for survival during host infection. To investigate LpxM Ab -dependent acyl chain placement, we used a genetic approach to confirm attachment of a lauroyl group to the R-2-hydroxymyristate in A. baumannii, which is the equivalent position that PagP-dependent myristate addition occurs in E. coli (37) . To do this, LpxM Ab was coexpressed with the lipid A deacylase PagL in an E. coli strain. PagL efficiently removes the 3-O-linked acyl chain of lipid A following transport of LPS/LOS to the outer membrane (Fig. 4A ) (38) . Lipid A isolated from cells coexpressing LpxM Ab and PagL was analyzed by MALDI-TOF mass spectrometry, and major species at m/z 1,725.2 and 1,753.2 were present in the spectra ( Fig. 4B ). These data indicate that deacylation at position 3 by PagL, which takes place in the outer membrane, is not inhibited by inner membrane-associated LpxM Ab -dependent acylation (Fig. 4B) . Furthermore, HCD and UVPD fragmentation spectra of m/z 1,712.12, corresponding to the ⌬lpxL Ab mutant, also confirmed that the secondary laurate group is attached at position 2 (see Fig. S4 in the supplemental material). On the basis of our genetic data and high-resolution HCD and UVPD data, we confirmed that LpxM Ab and PagP add a lauroyl group and a palmitoyl group, respectively, at the R-2-hydroxymyristate position of lipid A ( Fig. 1 and 4C ). In summary, LpxM Ab -dependent lauroyl group addition occurs at the R-3=-and R-2-hydroxymyrsitate positions of lipid A (Fig. 4C ).
In addition, lipid A from A. baumannii strains was analyzed by TLC; lipid A from the wild-type strain, lpxM Ab mutant, and all complemented A. baumannii strains migrated as doublets, indicating the presence of a modified fatty acid in all strains except the lpxL Ab mutant (Fig. 2A) . Mass spectrometry indicated a mass difference of 16 in lipid A, which is indicative of hydroxylation modification ( Fig. 2B and D) . Therefore, we concluded that the lpxL Abdependent acyl chain is hydroxylated. Hydroxylation of lipid A fatty acids is common in Gram-negative bacteria where LpxO hydroxylates fatty acids. Furthermore, BLAST analysis revealed that gene A1S_0308 encodes a putative A. baumannii LpxO homolog with 59% identity to Salmonella enterica serovar Typhimurium LT-2 LpxO.
A. baumannii lipid A differentially stimulates human TLR-4/MD-2. Microbes continuously challenge the host immune system, but mammals have evolved receptors like TLR-4/MD-2 to detect invading bacterial cells via pathogen-associated molecular patterns (39) . Specifically, the lipid A portion of Gram-negative bacterial LPS/LOS is a pathogen-associated molecular pattern that is bound by the TLR-4/MD-2 complex with high affinity (40) . The interaction between lipid A and TLR-4/MD-2 strongly activates MyD88-and TRIF-dependent innate immune pathways to result in inflammation and clearance of the infection via innate immune recruitment (41) . Coevolution of the TLR-4/MD-2 receptor and lipid A ligand has resulted in strong immune activation when hexa-acylated lipid A is detected. However, many pathogens modify the lipid A chemical structure to avoid TLR-4-dependent immune detection (8) . Therefore, we analyzed human TLR-4/MD-2 activation using LOS isolated from the A. baumannii acyltransferase mutants.
To analyze immune activation by A. baumannii LOS, we used a human embryonic kidney reporter cell line (HEK-blue; InvivoGen) that expressed the human TLR-4, MD-2, and CD-14 receptor complex along with the NF-B and activator protein-1-dependent reporter secreted embryonic alkaline phosphatase (SEAP) (9) . LOS was isolated and purified from wild-type, ⌬lpxL Ab , ⌬lpxM Ab , and complemented strains (see Fig. S5 in the supplemental material). Increasing concentrations of LOS were incubated with HEK-blue cells to activate potential signaling pathways. The wild type and the complemented strains activated reporter expression in a dose-dependent manner indicating that A. baumannii hepta-acylated lipid A activates the human TLR-4/ MD-2 innate immune pathway (Fig. 5) . In contrast, LOS stimu- (Fig. 5 ). Similar to findings in E. coli, the pattern of TLR-4/MD-2 reporter activation indicates that acylation of A. baumannii lipid A is important for immune recognition by the host immune system (8, 37) .
LpxM Ab protects A. baumannii from CAMPs. The innate immune system produces CAMPs that bind to and lyse Gramnegative bacteria through disruption of the outer membrane. CAMPs are directed to LPS/LOS on the bacterial surface by electrostatic interactions (42) . Presumably PagP-dependent lipid A palmitoylation increases the hydrophobic van der Waals forces of the lipid bilayer to prevent CAMP insertion and membrane disruption. In Salmonella, hepta-acylation of lipid A protected bacterial cells from vertebrate CAMPs such as C18G, an ␣-helical peptide found at the C terminus of the secreted cytokine human platelet factor IV (10, 43) .
Based on quantitative TLC analysis of wild-type A. baumannii lipid A, hepta-acylated lipid A dominated the cell surface ( Fig. 2A,  leftmost lane) . Therefore, we first determined whether heptaacylated lipid A in A. baumannii conferred resistance to vertebrate CAMPs. Increasing concentrations of the C18G CAMP facilitated concentration-dependent killing in all A. baumannii strains. Importantly, the lpxM Ab mutant displayed increased sensitivity to C18G, where a 1,000-fold decrease in the number of CFU per milliliter was recovered at a concentration of 10 g/ml compared to the wild-type strain. Complementation fully restored resistance of the lpxM Ab mutation back to wild-type levels, indicating that LpxM Ab -mediated hepta-acylation confers protection against vertebrate CAMPs in A. baumannii (Fig. 6A) .
Another class of CAMPs called polymyxins includes polymyxin B and E, which are lipopeptides synthesized by Grampositive soil bacilli. These cyclic peptides contain a hydrophobic tail that inserts into the membrane to kill by forming pores in the Gram-negative outer membrane (44) . Polymyxin B is currently used in topical solutions such as neosporin, while polymyxin E (colistin) is a last-line antimicrobial used to treat Gram-negative multidrug-resistant bacterial infections. We observed increased killing by polymyxin B (Fig. 6B) and colistin (Fig. 6C) , indicating that these drugs could kill A. baumannii more effectively when LpxM Ab -dependent acylation was inhibited. The enhanced killing that we observed was fully complemented when each gene was expressed in trans. Therefore, LpxM Ab -dependent acylation in 
A. baumannii promotes resistance not only to vertebrate CAMPs but also to medically relevant polymyxin antibiotics.
LpxM Ab is required for virulence in Galleria mellonella. A well-established model to determine virulence of A. baumannii strains is the Galleria mellonella infection model (45) (46) (47) . Importantly, a strong correlation between the virulence of several bacteria, including A. baumannii, in G. mellonella and mammalian virulence models has been established (47) (48) (49) . Furthermore, G. mellonella carries a gene that encodes a humoral immune response, which is activated when large bacterial loads are injected. While invertebrates do not mount an antibody response, within 3 h of challenge, antimicrobial peptides are synthesized and released into the hemolymph to neutralize the bacterial infection (50, 51) .
To determine the susceptibility of killing in the A. baumannii acyltransferase mutants, we injected equivalent numbers of CFU from wild-type, mutant, and complemented strains into G. mellonella and monitored bacterial killing. After 72 h, all wax moth larvae injected with the wild-type and complemented A. baumannii strains died, whereas all worms that were challenged with phosphate-buffered saline (PBS) and the A. baumannii ⌬lpxM Ab strain survived. In contrast, only one of the larvae injected with the A. baumannii LpxL Ab mutant survived (Fig. 7) . These data suggest that LpxM Ab -dependent lipid A acylation is important for A. baumannii survival and virulence in invertebrates.
LpxM Ab -dependent acylation of A. baumannii lipid A contributes to desiccation survival. A. baumannii is a nosocomial pathogen that persists on inanimate objects in hospitals for months and even years (52) . The organism's unique ability to survive under desiccative conditions results in increased infections and transmission rates. The molecular mechanisms that contribute to desiccation tolerance in A. baumannii have not been characterized and are not well understood. In other Gramnegative bacteria, proteins involved in exopolysaccharide biosynthesis, in maintaining protein stability, and in detoxification of reactive oxygen species were identified as important to desiccation resistance (53, 54) . However, the protective role of the outer membrane barrier has not been explored.
In order to further characterize our lipid A acyltransferase mutants, we subjected the wild type, ⌬lpxL Ab , ⌬lpxM Ab , and the complemented strains to a desiccation survival assay. Strains were spotted on agar in a 10-fold dilution series before and after desiccation on polystyrene ( Fig. 8; see Fig. S6 in the supplemental material). Following desiccation, bacterial CFUs were recovered for all strains except for the A. baumannii ⌬lpxM Ab strain, for which no viable cells were recovered at either cell density tested, indicating a Ͼ1,000-fold decrease in CFU (Fig. 8A and Fig. S6A ). In addition, we performed desiccation assays where we resuspended A. baumannii cells in human serum before desiccation. Following desiccation, cells were recovered in all groups and spotted ( Fig. 8B  and Fig. S6B ). However, we recovered 100-fold less of the lpxM Ab mutant strain following desiccation (Fig. 8B and Fig. S6B ). Under each condition, in trans expression of lpxM Ab fully complemented the mutant phenotype and restored bacterial survival to the wildtype level. These results suggest that the lipid components in the outer membrane contribute to desiccation survival in A. baumannii.
DISCUSSION
The lipid A domain of LPS/LOS provides Gram-negative bacteria with a formidable barrier to protect the cell from its environment. The work described in this study suggests that hepta-acylation of lipid A fortifies the outer membrane to protect A. baumannii from CAMPs and desiccation. While many pathogens synthesize hexaacylated lipid A under standard growth conditions, PagPdependent hepta-acylation of lipid A occurs upon exposure to stressful factors (10) . Hepta-acylation reinforces the outer membrane by packing the hydrophobic membrane with palmitate added at the R-2-hydroxymyristate position of lipid A (37). PagPdependent acylation of lipid A protects Gram-negative bacteria from antimicrobial peptides in vertebrate mucosal secretions (e.g., CAMPs) (10). Whereas most pathogens regulate synthesis of hepta-acylated lipid A by regulating PagP expression, A. baumannii does not carry a gene that encodes a PagP homolog and constitutively synthesizes hepta-acylated lipid A under standard growth conditions. The PagP-independent mechanism utilized by A. baumannii illustrates an additional strategy for the addition of a secondary acyl chain at position 2 on lipid A. Intriguingly, A. baumannii could have evolved its PagP-independent mechanism to continuously produce hepta-acylated lipid A on its surface due to the selective pressures encountered in its environmental niche. Since A. baumannii is primarily found in health care settings, assault by hospital-like environmental factors may suggest why A. baumannii encodes a LpxM dual acyltransferase homolog to continually reinforce its outer membrane.
The previously characterized LpxL and LpxM acyltransferases of E. coli add acyl chains to a specific site of the lipid A molecule in an ordered fashion (5-7). In contrast, our results suggest that the A. baumannii homologs LpxL Ab and LpxM Ab catalyze lipid A acylation independently of the other. Furthermore, the dual acyltransferase activity of LpxM Ab , illustrated in a heterologous E. coli system, involved a unique transferase activity where two lauroyl groups are attached to lipid A. While beyond the scope of this study, a more detailed examination of the LpxM Ab molecular structure could reveal the requirements that mediate the relaxed acyltransferase fidelity. Intriguingly, Moraxella catarrhalis, which is responsible for otitis media in infants and is closely related to Acinetobacter, also carries a gene that encodes an enzyme with potential dual acyltransferase activity. While A. baumannii adds two C 12:0 groups, M. catarrhalis adds two C 10:0 groups to lipid A, both of which are essential for its survival in the mouse lung and human serum (55) .
While the host immune system exploits a number of immune mechanisms to clear bacterial infections, a common lipid A structure, including the number, length, and arrangement of fatty acyl chains and exposed phosphates, is key (40) . The human TLR-4/ MD-2 receptor complex has evolved to bind hexa-acylated bisphosphorylated lipid A with high affinity to result in strong immune activation. TLR-4-dependent pathways include MyD88-and TRIF-dependent signaling cascades, which trigger an immune response at the site of infection (56) . While we cannot directly compare TLR-4/MD-2 activation by A. baumannii LOS to hepta-acylated E. coli LPS because of the different lipid A acyl chain lengths, hepta-acylated LOS extracted from wild-type A. baumannii activated a human TLR-4 reporter cell line (Fig. 5) . In contrast, hexa-acylated lpxL Ab and penta-acylated lpxM Ab mutants failed to stimulate our reporter cell line, suggesting that the acyl chains added via these enzymes are important for human TLR-4/MD-2 recognition of Acinetobacter LOS. The inability of the lpxM Ab and lpxM Ab mutants to stimulate human TLR-4 illustrates the importance of acyl chain placement in human immune recognition of LPS/LOS. In addition to immune surveillance systems, the mammalian innate immune system secretes CAMPs to deter bacterial invasion into host tissues. In Salmonella, PagP-dependent hepta-acylation of lipid A increased resistance to vertebrate CAMPs, such as C18G CAMP, which is a cytokine secreted by host cells to inhibit bacterial growth and prevent infection (57) . However, hepta-acylation did not result in increased resistance to polymyxin CAMPs (10) . Similar to Salmonella pagP mutants, A. baumannii lpxM Ab mutants exhibited sensitivity to C18G (Fig. 6A) . However, removal of lpxM Ab also sensitized A. baumannii to the bactericidal effects of polymyxin CAMPs (Fig. 6B and C) . Whereas pagP mutants produce hexa-acylated lipid A, our analysis showed that the A. baumannii lpxM Ab mutant synthesizes penta-acylated lipid A (Fig. 2D) . Therefore, we suspect that the observed polymyxin killing sensitivity results from the loss of two laurate acyl chains from A. baumannii lipid A. Importantly, LpxM Ab inhibition effectively sensitizes A. baumannii cells to a wide range of host and polymyxin CAMPs, suggesting potential for enhanced drug delivery as a synergistic antimicrobial agent.
To demonstrate the essentiality of LpxM Ab -dependent survival in a host, we used an invertebrate model to assess CAMPdependent killing. Galleria mellonella provides an optimal model, because it carries a gene(s) encoding a humoral immune response that synthesizes and releases antimicrobial peptides into the hemolymph upon sensing bacterial assault (50) . Our results demonstrate that deletion of lpxM Ab resulted in attenuated virulence (Fig. 7) . Production of antimicrobial peptides likely plays a large role in neutralizing A. baumannii infections (58) . The inability of the lpxM Ab mutant A. baumannii to kill wax moth larvae is likely because the humoral antimicrobial peptide response can rapidly lyse the penta-acylated lipid A lpxM Ab mutant, but not cells that synthesize wild-type lipid A.
Furthermore, CAMPs that target the outer membrane such as magainin and cecropin are potential alternatives to currently prescribed antibiotics. It was previously demonstrated that magainin disorders the outer membrane acyl chains of Gram-negative bacteria, whereas cecropin disrupts lipid moieties in biological membranes to form pores (59) (60) (61) . These CAMPs and countless others could act synergistically with an LpxM Ab inhibitor to effectively lyse multidrug-resistant A. baumannii cells, providing an innovative antimicrobial strategy.
Unexpectedly, our analysis of lipids in the outer membrane determined that the fatty acid lipid content of lipid A is important for A. baumannii survival during desiccation ( Fig. 8; see Fig. S6 in the supplemental material). While a detailed understanding of the factors required for desiccation survival in any bacterium is lacking, surface structures such as carbohydrates and oxidative damage have been hypothesized to play a role. We suspect that the penta-acylated lipid A outer membrane synthesized by the lpxM Ab mutant is more fluid than the wild-type hepta-acylated membrane. Increased membrane fluidity would likely permit leakage of water and hydrophilic nutrients out of the cell. The resultant loss of essential growth factors would potentially be deadly to the bacterial cell. In this study, the penta-acylated A. baumannii bacteria could not survive for even 48 h in a desiccative environment, while the wild-type A. baumannii cells could persist under desiccative conditions for weeks and even months. Identification of outer membrane lipid species as important factors for desiccation survival may aid in the development of new antiseptics.
MATERIALS AND METHODS
Bacterial strains and growth. All strains and plasmids used in this study are listed in Table S1 in the supplemental material. A. baumannii ATCC 17978 strains were initially grown from freezer stocks on Luria-Bertani (LB) agar at 37°C. Isolated colonies were used to inoculate LB broth at 37°C. Carbenicillin was used at 150 g/ml, and kanamycin was used at 25 or 7.5 g/ml for selection.
Construction of mutant and complementation A. baumannii strains. Primers used in this study are listed in Table S2 in the supplemental material. All A. baumannii genetic mutants were engineered as previously described (31) . In brief, A. baumannii ATCC 17978 carrying plasmid pMMB67EH containing the REC Ab coding sequences was diluted from a culture grown overnight into LB broth at an optical density at 600 nm (OD 600 ) of 0.05 and grown for 45 min. Expression of REC Ab (pAT03) was induced by the addition of 2 mM IPTG, and cells were grown at 37°C until they were in mid-log growth phase (OD 600 of 0.4). After the cells were washed in ice-cold 10% glycerol, 10 10 cells were electroporated in a 2-mm cuvette at 1.8 mV with 5 g of a recombineering linear PCR product. The cells were immediately grown for 4 h in 4 ml of LB broth with 2 mM IPTG and plated on LB agar containing 7.5 g/ml or 25 g/ml of kanamycin. All mutants were verified by PCR and sequenced.
To cure isolated mutants of the pMMB67EH::REC Ab Tet r plasmid following mutant isolation, strains were streaked for isolated colonies on 2 mM NiCl 2 to select for cells that have lost the tetracycline cassette (62) . Cured mutants were electroporated with pMMBR67EH carrying the FLP recombinase (pAT04). Cells were recovered for 1 h in 4 ml of LB broth and plated on LB agar containing 2 mM IPTG to induce expression of the FLP recombinase. Excision of the kanamycin cassette was confirmed by PCR and sequenced.
To complement A. baumannii mutants, the coding sequences from A1S_0431 (lpxL Ab ) and A1S_2609 (lpxM Ab ) were cloned into the KpnI and SalI sites in pMMB67EH. The plasmids were expressed in the respective mutants, and all strains were grown in 0.05 mM IPTG for expression.
Isolation of lipid A. Isolation of lipid A for TLC analysis involved 32 P radiolabeling of whole cells as previously described (63) . In brief, 14 ml of A. baumannii was grown at 37°C to an OD 600 of 1.0. Bacteria were harvested by centrifugation at 10,000 ϫ g for 10 min. Lipid A extraction was carried out by mild-acid hydrolysis as previously described (64) .
Isolation and quantification of LOS. LOS was isolated as previously described (63) . In brief, A. baumannii (1 liter) was grown at 37°C to an OD 600 of 1.0. Cells were harvested by centrifugation and lyophilized overnight. The phenol-water method was used to isolate LOS (65) . Quantification of LOS was performed by using the 3-deoxy-3-manno-octulosonic acid (Kdo) colorimetric assay as previously described (66) .
Mass spectrometry. For mass spectrometry, lipid A was analyzed using a MALDI-TOF/TOF (ABI 4700 proteom ics analyzer) mass spectrometer in the negative ion mode as previously described (63) . All UVPD and HCD spectra were collected in the negative ion mode on a Thermo Scientific Orbitrap Elite mass spectrometer (Bremen, Germany) modified with a Coherent ExciStar XS ArF excimer laser (Santa Clara, CA), as previously described (34, 35) . HCD was performed with the normalized collision energy (NCE) of 55% with a cell pressure of approximately 0.13 ϫ 10 2 Pa. UVPD was performed with the laser emitting 193-nm photons at 4 mJ per laser pulse with four pulses per scan. The laser pulse repetition rate was 500 Hz. The instrument was operated at 120,000 resolving power with a precursor isolation window of 5 m/z. All samples were dissolved in 50:50 methanol (MeOH)-CHCl 3 and directly infused into the mass spectrometer at a rate of 3 l/min with a spray voltage of 4 kV. The presented HCD and UVPD spectra are composed of 104to 330 averages.
TLR-4 signaling assays. The HEK-blue human TLR-4 (hTLR-4) cell line was maintained according to the manufacturer's specifications (InvivoGen). LOS samples were serially diluted for assays as previously described (9, 63) . At least two biological replicates were each done in triplicate, and one representative set was shown.
Bactericidal assays. Overnight cultures of A. baumannii strains were diluted to an OD 600 of 0.15, and 100 l was added to three replicate wells on a 96-well microtiter plate. CAMPs were added to each well at the desired concentration, and the plate was incubated at 37°C for 2 h (10). Serial dilutions were plated on LB agar and incubated overnight at 37°C. Colony counts were reported as CFU per milliliter. Two biological replicates were performed in triplicate for each strain, and all groups were included in the reported data.
Desiccation assays. Wild-type and mutant A. baumannii strains were diluted to OD 600 s of 0.1 and 0.01 in 10-l and 100-l volumes, respectively, and diluted in LB broth or human serum. Predesiccated samples were serially diluted in 10-fold increments and spotted. Samples were desiccated on polystyrene at 25°C and 40% humidity for 48 h. Following desiccation, samples were resuspended in LB broth, serially diluted in 10-fold increments, and spotted. Survival of each strain was assessed by the relative loss of CFU compared to the wild type.
Galleria mellonella virulence assay. The Galleria mellonella virulence assay was performed as previously described (45) . Larvae (Vanderhorst, Inc., St. Marys, OH) were stored in the dark and used within 7 days of receipt. Ten randomly chosen caterpillars of similar weight were used for each group in the experiment. Following bacterial injection, caterpillars were stored at 37°C and monitored every 12 h for death. Caterpillars were considered dead when they became nonresponsive to touch. The experiment was performed in triplicate with data from one representative group reported.
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